MacDonald James J.
EVP & General Counsel at SANA
- Sold, on record
- $2k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Feb 18, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SANASana Biotechnology, Inc.EVP & General Counsel
Sales by reason
0
Routine
1
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Feb 18, 2022Plan not stated
Sold 0.1% of their holdings
$2k333 shares at $6.28
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | Jun 15, 2022 | SANA | EVP & General Counsel | Exercised or settledStock Option (Right to Buy) | 66,796 | 51,954 | SEC | ||
| Jun 13, 2022 | Jun 15, 2022 | SANA | EVP & General Counsel | Exercised options | 66,796 | $1.48 | $99k | 497,396 | SEC |
| May 13, 2022 | Jun 15, 2022 | SANA | EVP & General Counsel | Awarded | 1,183 | $4.28 | $5k | 430,600 | SEC |
| Mar 3, 2022 | Mar 8, 2022 | SANA | EVP & General Counsel | AwardedStock Options (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Feb 18, 2022 | Feb 23, 2022 | SANA | EVP & General Counsel | Sold | 333 | $6.28 | $2k | 429,417 | SEC |
| Nov 15, 2021 | Feb 23, 2022 | SANA | EVP & General Counsel | Awarded | 1,000 | $18.23 | $18k | 429,750 | SEC |
| Feb 8, 2021 | Feb 10, 2021 | SANA | Officer | ConvertedSeries A-1 Convertible Preferred Stock | 101,562 | 0 | SEC | ||
| Feb 8, 2021 | Feb 10, 2021 | SANA | Officer | Converted | 101,562 | 7,812 | SEC |